231 related articles for article (PubMed ID: 10609993)
1. Abnormal uterine cavity: differential diagnosis with MR imaging.
Imaoka I; Sugimura K; Masui T; Takehara Y; Ichijo K; Naito M
Magn Reson Imaging; 1999 Dec; 17(10):1445-55. PubMed ID: 10609993
[TBL] [Abstract][Full Text] [Related]
2. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
[TBL] [Abstract][Full Text] [Related]
3. MRI findings including gadolinium-enhanced dynamic studies of malignant, mixed mesodermal tumors of the uterus: differentiation from endometrial carcinomas.
Ohguri T; Aoki T; Watanabe H; Nakamura K; Nakata H; Matsuura Y; Kashimura M
Eur Radiol; 2002 Nov; 12(11):2737-42. PubMed ID: 12386766
[TBL] [Abstract][Full Text] [Related]
4. Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones.
Kilickesmez O; Bayramoglu S; Inci E; Cimilli T; Kayhan A
Acta Radiol; 2009 Apr; 50(3):340-7. PubMed ID: 19235579
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results.
Fujii S; Matsusue E; Kigawa J; Sato S; Kanasaki Y; Nakanishi J; Sugihara S; Kaminou T; Terakawa N; Ogawa T
Eur Radiol; 2008 Feb; 18(2):384-9. PubMed ID: 17917730
[TBL] [Abstract][Full Text] [Related]
6. MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images.
Hricak H; Finck S; Honda G; Göranson H
AJR Am J Roentgenol; 1992 May; 158(5):1043-50. PubMed ID: 1566664
[TBL] [Abstract][Full Text] [Related]
7. Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging.
Yamashita Y; Mizutani H; Torashima M; Takahashi M; Miyazaki K; Okamura H; Ushijima H; Ohtake H; Tokunaga T
AJR Am J Roentgenol; 1993 Sep; 161(3):595-9. PubMed ID: 8352114
[TBL] [Abstract][Full Text] [Related]
8. Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T--initial experience.
Hori M; Kim T; Onishi H; Ueguchi T; Tatsumi M; Nakamoto A; Tsuboyama T; Tomoda K; Tomiyama N
Radiology; 2011 Jan; 258(1):154-63. PubMed ID: 21045182
[TBL] [Abstract][Full Text] [Related]
9. [Value of MRI in symptomatic patients treated with tamoxifen].
Taïeb S; Ceugnart L; Chevalier A; Cabaret V; Leblanc E; Fournier C; Besson P
J Radiol; 2003 Jan; 84(1):33-9. PubMed ID: 12637885
[TBL] [Abstract][Full Text] [Related]
10. [Sarcomas and mixed mesodermal tumors of the uterus].
Günthert AR
Ther Umsch; 2011 Oct; 68(10):559-64. PubMed ID: 21968895
[TBL] [Abstract][Full Text] [Related]
11. Endometrial stromal sarcoma of the uterus: MR and US findings.
Gandolfo N; Gandolfo NG; Serafini G; Martinoli C
Eur Radiol; 2000; 10(5):776-9. PubMed ID: 10823632
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of diagnostic effectiveness of the method of diffusion-weighted MR-images in diagnosis of pathology of the uterine body].
Stolyarova IV; Yakovleva EK; Sharakova VV
Vopr Onkol; 2015; 61(6):986-93. PubMed ID: 26995993
[TBL] [Abstract][Full Text] [Related]
13. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
Hauth E; Libera H; Kimmig R; Forsting M
Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
[TBL] [Abstract][Full Text] [Related]
14. Prospective comparison of biopsy results from curettage and hysteroscopy in postmenopausal uterine bleeding.
Lee DO; Jung MH; Kim HY
J Obstet Gynaecol Res; 2011 Oct; 37(10):1423-6. PubMed ID: 21651668
[TBL] [Abstract][Full Text] [Related]
15. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.
Sumi A; Terasaki H; Sanada S; Uchida M; Tomioka Y; Kamura T; Yano H; Abe T
Magn Reson Med Sci; 2015; 14(4):295-304. PubMed ID: 26104072
[TBL] [Abstract][Full Text] [Related]
16. MR assessment of myometrial invasion in women with endometrial cancer: discrepancy between T2-weighted imaging and contrast-enhanced T1-weighted imaging.
Lee YJ; Moon MH; Sung CK; Chun YK; Lee YH
Abdom Radiol (NY); 2016 Jan; 41(1):127-35. PubMed ID: 26830619
[TBL] [Abstract][Full Text] [Related]
17. MR imaging of pelvic masses in women: contrast-enhanced vs unenhanced images.
Thurnher SA
AJR Am J Roentgenol; 1992 Dec; 159(6):1243-50. PubMed ID: 1442393
[TBL] [Abstract][Full Text] [Related]
18. MR imaging of the uterus: low-signal-intensity abnormalities of the endometrium and endometrial cavity.
Brown JJ; Thurnher S; Hricak H
Magn Reson Imaging; 1990; 8(3):309-13. PubMed ID: 2366643
[TBL] [Abstract][Full Text] [Related]
19. MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: histopathologic correlation.
Ascher SM; Johnson JC; Barnes WA; Bae CJ; Patt RH; Zeman RK
Radiology; 1996 Jul; 200(1):105-10. PubMed ID: 8657895
[TBL] [Abstract][Full Text] [Related]
20. Direct uterine sampling using the SAP-l sampler device to detect endometrial lesions during histopathological examination.
Li MX; Zhou R; Liu C; Shen DH; Zhao LJ; Wang JL; Wei LH
Eur J Gynaecol Oncol; 2017; 38(2):221-226. PubMed ID: 29953784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
